Effect of MAXOMAT ® on the Growth of Small Children to NOONAN's Syndrome
NCT00452725
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
36
Enrollment
INDUSTRY
Sponsor class
Conditions
Noonan Syndrome
Interventions
DRUG:
MAXOMAT ®, biosynthetic growth hormone
Sponsor
Sanofi